ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Global Wellness Strategies Inc

Global Wellness Strategies Inc (LOAN)

0.25
0.00
( 0.00% )
Updated: 20:00:00

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.25
Bid
0.15
Ask
0.25
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.25
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

LOAN Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
156-0.04-13.79310344830.290.3350.11103720.26147901CS
2600.11585.18518518520.1350.50.03610760.13276247CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CAUDCollective Audience Inc
$ 0.8139
(108.69%)
124.09M
DCPHDeciphera Pharmaceuticals Inc
$ 25.22
(72.15%)
37.69M
HWHHWH International Inc
$ 2.50
(37.36%)
20.83M
SINTSiNtx Technologies Inc
$ 0.055
(36.14%)
119.36M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 9.45
(32.17%)
51.95M
CLVRClever Leaves Holdings Inc
$ 1.575
(-61.68%)
571.5k
ADXNAddex Therapeutics Ltd
$ 8.40
(-47.83%)
109.41k
TSDDGraniteShares ETF Trust GraniteShares
$ 16.9278
(-32.02%)
901.28k
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 26.7699
(-31.83%)
4.69M
MFImF International Ltd
$ 1.62
(-30.47%)
2.26M
TSLATesla Inc
$ 195.24
(16.01%)
129.52M
CAUDCollective Audience Inc
$ 0.8139
(108.69%)
124.09M
SINTSiNtx Technologies Inc
$ 0.055
(36.14%)
119.36M
SOFISoFi Technologies Inc
$ 7.09
(-9.91%)
104.72M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 9.45
(32.17%)
51.95M

LOAN Discussion

View Posts
WatchinOut WatchinOut 5 years ago
Likely no longer a Redfund portfolio company. Check the Annual MD&A posted 1/28. Biolog note is listed as “impaired” and management deems the account uncollectible.
👍️0
LowFloatLopes LowFloatLopes 5 years ago
You can hit a golf ball from Rxmm office to red fund office lol this is gonna be huge for both companies...aggl (Rxmm) is sitting at .79 today and should see $20+ this year once they start filing the SS is gorgeous
👍️0
LowFloatLopes LowFloatLopes 5 years ago
Rxmm is already in the middle of their reverse merger go check it out AGGL ...connect the dots it’s gonna be massive I’m all in there....it just led me here actually
👍️0
Peron Peron 6 years ago
NEWS out!

Redfund Client Biominerales Pharma Colombia Announces First Purchase Order
https://web.tmxmoney.com/article.php?newsid=5864527430213220&qm_symbol=LOAN:CNX
👍️0
Peron Peron 6 years ago
Intraday new ATH @0,70 CAD
ASK 0,72

$$$$
👍️0
Peron Peron 6 years ago
Just google RxMM Health. They run the worlds largest hemp cultivation project!!

Redfund has its stake in it.

RxMM Ipo in Q4 2018!!

$$$$
👍️0
Peron Peron 6 years ago
And confirmed.
So new ATH at 0,69 CAD!
Still just 26Mio Cad MC!
👍️0
Peron Peron 6 years ago
0,69 Pre-ASK
👍️0
Peron Peron 6 years ago
It holds
$$$
👍️0
Peron Peron 6 years ago
NEW ATH 0,65 CAD
NICE
👍️0
Peron Peron 6 years ago
Redfund yesterday closed at 0,60 CAD which was Day High and which is All Time High!!!

👍️0
Peron Peron 6 years ago
Extract:
Biolog’s CEO Bruce Bauer stated: “Our license from Lexaria is what separates Biolog products from all others. By incorporating the DehydraTECH™ drug delivery platform into our products, the bitterness and the earthy taste of cannabis oil are masked, and this technology ensures quick and effective transportation into the bloodstream without degradation in the stomach or liver. This equates to decreased onset times, a 300% increase in bioavailability and more accurate dosing. The cannabidiol (CBD) market is projected to reach $2.1 billion by 2020. In my opinion our work with Lexaria Biosciences will prove to be a highly and mutually beneficial business relationship.”
👍️0
Peron Peron 6 years ago
NEWS:
Redfund Client Biolog Inc. Provides Progress Report

https://web.tmxmoney.com/article.php?newsid=4689295629727003&qm_symbol=LOAN:CNX
👍️0
Peron Peron 6 years ago
Symbol: LOAN
👍️0
dollar dude dollar dude 6 years ago
Hey guy I am trying the CNSX symbol but getting nowhere with it. Any ideas?
👍️0
Peron Peron 6 years ago
+50% and increasing volume.

NICE!!!
👍️0
Peron Peron 6 years ago
+40%! Am I the only lucky guy here?
👍️0
Peron Peron 6 years ago
Yeahh, c´mon Baby, further up $$$
👍️0
Peron Peron 6 years ago
Anybody in here?
👍️0
Peron Peron 6 years ago
Now 80% up......
👍️0
Peron Peron 6 years ago
70% UP in GERMANY due to todays news has been released prior Canada market opening.

In Europe still listed as Parana Copper:

https://www.onvista.de/aktien/PARANA-COPPER-Aktie-CA75745T1084
👍️0
Peron Peron 6 years ago
From todays PR:

BMP’s headquarters and lab facility are located in Bogata and it has a wide range of operations countrywide. In Corinto, the base cannabis farm features both greenhouse and outside growing operations totalling almost 2 million sq. ft. of outdoor and 15,000 sq. ft. of greenhouse, producing high volumes of organic medicinal cannabis. In Tulua, BMP has another farm for growing industrial hemp for CBD. The first phase in Tulua is projected to yield 1.2-1.4 million pounds of biomass per year.

Can anybody compare to other Cannabis companies?

600.000 to 700.000 kilograms per year is quite impressive!

And they received the licence some weeks ago!
👍️0
Peron Peron 6 years ago
Very low volume last Friday. That should change today.

Does anybody has this stock on watch or is already in?
👍️0
Peron Peron 6 years ago
But what sounds quite promising is todays pre-market update on the operating activities in Colombia:



THE TRAILBLAZER OF MEDICAL CANNABIS IN COLOMBIA
LICENCED GLOBAL EXPORTER OF CBD OIL

VANCOUVER, British Columbia, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (Redfund or the “Company”) is pleased to update operations of Biominerales Pharma Colombia (‘BMP Colombia”), a first mover and the trailblazer of medical cannabis in Colombia.

Biominerales Pharma Corp. has the trifecta of licenses in Colombia allowing them to grow, process and export CBD oil beyond South America to the global marketplace. Its extensive in-country farming operations plus a state-of-the-art GMP processing facility in Bogota (coming online in 2019) make BMP the perfect supplier, partner and distributor for Canadian LPS and global partnerships.

BMP’s headquarters and lab facility are located in Bogata and it has a wide range of operations countrywide. In Corinto, the base cannabis farm features both greenhouse and outside growing operations totalling almost 2 million sq. ft. of outdoor and 15,000 sq. ft. of greenhouse, producing high volumes of organic medicinal cannabis. In Tulua, BMP has another farm for growing industrial hemp for CBD. The first phase in Tulua is projected to yield 1.2-1.4 million pounds of biomass per year. In Mondomo, BMP is completing a lab where the chief agronomist will execute a process of DNA testing and growing in-vitro to create a super strain of seeds and plants with the highest quality plants free of disease. (https://biomineralespharma.com)

BMP are planning to open a series of mobile labs in addition to medical clinics to act as treatment and dispensary distribution centers. This will be executed as an extension of Biomerales Pharma Colombia’s medical partner Carlos Rios’ private Clinica Santuario, who is also a member of the BMP Advisory Board.

Redfund Capital announced that it completed its first international financing with Biominerales Pharma Corp. on August 30th 2018. Redfund and BMP signed a 2 year term convertible secured promissory note on August 23 for US$3,000,000 at an annual interest rate of 14%.

“Last week we were granted our Medicinal Cannabis licensure for the national Colombian market. This is a great accomplishment and it will allow us to expand via well known strategic partnerships in cannabis medicine benefiting the Colombian population,” stated BMP CEO Adriana Rios Garcia.

“Biomerales Pharma has become the #1 trailblazer in Colombia medical cannabis. With only a few weeks remaining before their expected approval to start government certification for 25 different cannabis medicinal genetics, they have possibly outperformed every cannabis company in Colombia with their low cost budget, experienced and well known Colombian management team and comprehensive medical platform. Redfund will continue to support BMP and looks forward to helping them become the #1 medical cannabis company in South America,” stated Meris Kott, CEO.
👍️0
Peron Peron 6 years ago
This stock is CSE-listed just since a month and has its stake in some very interesting Pot companies.

Here some recent news:

https://www.redfundcapital.com/redfund-capital-corp-opens-medical-cannabis-merchant-bank/

https://www.redfundcapital.com/redfund-capital-corp-funds-biolog-inc/

https://www.redfundcapital.com/redfund_finances_biominerals_pharma/

https://www.redfundcapital.com/redfund_capital_appoints_amanda_de_freitas_as_director/

https://www.redfundcapital.com/redfund-capital-partners-with-us-based-plant-life/
👍️0
Peron Peron 6 years ago
Redfund Cap Corp is a Cannabis Merchants Bank

https://www.redfundcapital.com/

Outstanding shares: 41 Mio
Current Market capitalisation: 13Mio CAD
👍️0

Your Recent History

Delayed Upgrade Clock